Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects

Glycobiology
Delphi Chatterjee, K H Khoo

Abstract

Detailed structural and functional studies over the last decade have led to current recognition of the mycobacterial lipoarabinomannan (LAM) as a phosphatidylinositol anchored lipoglycan with diverse biological activities. Fatty acylation has been demonstrated to be essential for LAM to maintain its functional integrity although the focus has largely been on the arabinan motifs and the terminal capping function. It has recently been shown that the mannose caps may be involved not only in attenuating host immune response, but also in mediating the binding of mycobacteria to and subsequent entry into macrophages. This may further be linked to an intracellular trafficking pathway through which LAM is thought to be presented by CD1 to subsets of T-cells. The implication of LAM as major histocompatibility complex (MHC)-independent T-cell epitope and the ensuing immune response is an area of intensive studies. Another recent focus of research is the biosynthesis of arabinan which has been shown to be inhibitable by the anti-tuberculosis drug, ethambutol. The phenomenon of truncated LAM as synthesized by ethambutol resistant strains provides an invaluable handle for dissecting the array of arabinosyltransferases involved, as well as g...Continue Reading

References

Apr 1, 1992·Infection and Immunity·P F BarnesR L Modlin
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·K Takayama, J O Kilburn
Jan 1, 1995·Advances in Immunology·S A Porcelli
Jul 14, 1995·Science·P A SielingP J Brennan
Jan 1, 1995·Annual Review of Biochemistry·P J Brennan, H Nikaido
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·L DengM R McNeil
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangW N Rom
Nov 1, 1993·Journal of General Microbiology·S PrinzisP J Brennan
Jan 15, 1994·The Biochemical Journal·A Lemassu, M Daffé
Jan 1, 1993·Analytical Biochemistry·K Leopold, W Fischer
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·K MikusováP J Brennan
Feb 1, 1996·Current Opinion in Immunology·A MeliánM B Brenner
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E BelangerJ M Inamine
May 1, 1997·The Journal of Clinical Investigation·D JullienR L Modlin
Jul 18, 1997·The Journal of Biological Chemistry·G S BesraP J Brennan

❮ Previous
Next ❯

Citations

Sep 25, 2004·Medicinal Research Reviews·Rama P TripathiVinod K Tiwari
Jul 1, 2001·Indian Journal of Clinical Biochemistry : IJCB·S Mitra, H R Das
Jun 1, 2005·Journal of the American Society for Mass Spectrometry·Christopher J PetzoldJulie A Leary
Dec 26, 2001·Immunology Letters·Françoise GuinetGabriel Gachelin
Apr 11, 2001·Journal of Microbiological Methods·B HamasurS B Svenson
May 27, 2003·Biochimie·Jérôme NigouGermain Puzo
Nov 18, 1998·Current Opinion in Structural Biology·B J Mengeling, S J Turco
May 17, 2001·Bioorganic & Medicinal Chemistry·J R BrownD Chatterjec
Dec 28, 1999·Microbes and Infection·G R Strohmeier, M J Fenton
Sep 21, 2000·Environmental Toxicology and Pharmacology·K HuttunenM Hirvonen
May 3, 2003·Trends in Molecular Medicine·Yvette van KooykTeunis B H Geijtenbeek
Oct 1, 2011·The Journal of Physical Chemistry. a·R ParthasarathiS Gnanakaran
Jun 24, 2010·Chemical Communications : Chem Comm·Laxmansingh T PadiyarShang-Cheng Hung
Aug 18, 2000·Immunology and Cell Biology·E R Rhoades, H J Ullrich
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Devinder KaurMary Jackson
Oct 24, 2012·The Journal of Biological Chemistry·Arek K RainczukPaul K Crellin
Jan 8, 2003·The Journal of Experimental Medicine·Teunis B H GeijtenbeekYvette Van Kooyk
Oct 6, 2005·The Journal of Experimental Medicine·Peter B KangLarry S Schlesinger
Aug 28, 2010·Journal of Biochemistry·Hiroyuki MoriiYosuke Koga
Jan 13, 2000·Immunological Reviews·D B MoodyS A Porcelli
Jun 3, 2009·Transboundary and Emerging Diseases·L Guenin-MacéC Demangel
Jan 5, 2006·Applied and Environmental Microbiology·Yoshitaka YamazakiLuiz E Bermudez
Jul 19, 2000·Infection and Immunity·C Astarie-DequekerI Maridonneau-Parini
Aug 14, 2001·Infection and Immunity·J R SchwebachA Glatman-Freedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.